Commonwealth Equity Services
STML

Commonwealth Equity Services’s Stemline Therapeutics, Inc. STML Stock Holding History

Commonwealth Equity Services’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-23,909
Closed -$115K – 3043
2020
Q1 		$115K Buy
+23,909
New +$155K ﹤0.01% 2548

Commonwealth Equity Services's STML Position: Q2 2020 in Review

Commonwealth Equity Services sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 23,909 shares — an estimated $115K sold.

Commonwealth Equity Services first reported a position in STML in Q1 2020 and held it in 1 quarter. The position peaked at $115K in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Commonwealth Equity Services reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Commonwealth Equity Services sold 23,909 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $115K.
  • Commonwealth Equity Services first reported a position in Stemline Therapeutics, Inc. in Q1 2020 and held it in 1 quarter.
  • Commonwealth Equity Services's Stemline Therapeutics, Inc. position peaked at $115K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Commonwealth Equity Services's 13F filing for Q2 2020, filed 12 Aug 2020.